Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Terminated 5Withdrawn 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 17Thoracic 6Lymphoid 6Genitourinary 6Gastrointestinal 6Breast 3Tumor-Agnostic 2Sarcoma 2Gynecologic 2Endocrine 2Dermatologic 2Plasma cell 1Other solid neoplasm 1Head & Neck 1

Conditions

Colonic Neoplasms 2Stomach Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 931Irinotecan 818Bevacizumab 805Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 324Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × antineoplaston A10 × Gastrointestinal × Clear all
NCT00003487 2021-05-14

Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus

Burzynski Research Institute

Phase 2 Terminated
8 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00003531 2021-01-07

Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer

Burzynski Research Institute

Phase 2 Terminated
15 enrolled 5 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00003530 2017-11-21

Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

Burzynski Research Institute

Phase 2 Terminated
3 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00003524 2017-09-29

Antineoplaston Therapy in Treating Patients With Stomach Cancer

Burzynski Research Institute

Phase 2 Terminated
1 enrolled
Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT00003485 2017-09-28

Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer

Burzynski Research Institute

Phase 2 Terminated
15 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00003486 2013-07-10

Antineoplaston Therapy in Treating Patients With Colon Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡